60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 1, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
Deal Size

Company Description

60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.

We have successfully achieved regulatory approval of Arakoda, a malaria preventative treatment that has been on the market since late 2019.

Currently, 60P’s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.

60 Degrees Pharmaceuticals, Inc.
Country United States
Founded 2010
IPO Date Jun 1, 2023
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2
CEO Geoffrey S. Dow

Contact Details

1025 Connecticut Avenue NW Suite 1000
Washington, DC, 20036
United States
Phone (202) 327-5422
Website 60degreespharma.com

Stock Details

Ticker Symbol SXTP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001946563
Employer ID 45-2406880
SIC Code 2834